Book Value per Share: Bone Biologics (BBLG)

Graphic logo of Bone Biologics Corporation (BBLG)

Bone Biologics acts as an innovator in tissue regeneration, establishing scientific authority within orthopedics. This chart on GURU.Markets reflects the dynamics of equity per share, where the 2.17 mark indicates the current state. Despite the potential of biopolymer matrices established in surgical standards, Bone Biologics currently has no commercial products and is consuming liquidity for clinical trials.

Bone Biologics Corporation - BBLG Net Assets per Share (period 07/04/2022 - 10/27/2026)

Summary analytical data breakdowns for bonebiologics.com (BBLG)

- price and consensus price forecast:
Price Chart Bone Biologics Corporation|BBLG - Price Target Chart
- market capitalization data:
Market Capitalization Bone Biologics Corp|BBLG - Full Takeover Company Value
- book capitalization data:
Net Assets per Single Share Bone Biologics|BBLG - Book Valuation of Business|Market Value to Book Value Ratio bonebiologics.com|BBLG - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital Bone Biologics|BBLG - Long-Term Liabilities to Capital|Short-Term Debt to Capital Bone Biologics Corp|BBLG - Company Total Debt|Debts to Book Capitalization Bone Biologics Corp
Analysis of all company metrics:Bone Biologics Corporation BBLG
Finished products of bonebiologics.com

Bone Biologics maintains a niche in orthopedics, where market capitalization depends on the value of patents and equipment. By analyzing the book value per common share indicator, an investor can see the residual value of assets minus liabilities, which is critical when accounting for biohazardous waste disposal costs. Growth in this metric confirms the strengthening of the company's material base, providing a long-term margin of safety for the business.

Competitors of Bone Biologics (BBLG)

BSX - Net Assets per Single Share|EW - Net Assets per Single Share|Book Value per Share RMD (ResMed Inc.)|PODD (insulet.com) - Book Value of One Share|ZBH: Net Assets per Single Share|Net Assets per Share COO|ALGN - Net Assets per Single Share|Share Book Value NuVasive (GMED)|TMDX: Book Value per Share|Net Asset Value per Share atecspine.com ATEC|AORT: Book Value per Share|ENOV - Accounting Value per Share|Integra - Book Value per Share|Establishment Labs Inc (ESTA) - Net Assets per Share|BBNX (Beta Bionics Inc) - Book Value per Share|Book Value per Share IRMD|Net Assets per Single Share Embecta (EMBC)|Net Assets per Single Share Tandem Diabetes Care Inc (TNDM)|Book Value per Share AXGN|SIBN - Net Assets per Share|Accounting Value per Share Orthofix Medical Inc.|BVS - Share Book Value|Book Value per Share KIDS|Treace Medical Concepts Inc (TMCI) - Net Asset Value per Share|Book Value per Share Strata Critical Medical Corp (SRTA)|Equity per Share Carlsmed Medical (CARL)|RxSight, Inc. (RXST) - Accounting Value per Share|Accounting Value of a Share CLPT (clearpointneuro.com)|Stereotaxis - Net Assets per Single Share|Accounting Value per Share Neuronetics Inc. STIM|SGHT (Sight Sciences, Inc) - Book Value per Share|OBIO - Net Asset Value per Share|Book Value per Share anikatherapeutics.com|inspiremd.com (NSPR) - Equity per Share|ZJYL: Book Value per Share|Net Assets per Share Vivani|Book Value per Share XTNT (Xtant Medical Holdings)|Accounting Value per Share NeuroOne Medical Technologies Corp. (NMTC)|Book Value per Share MODD (Modular Medical, Inc.)|myomo.com - Book Value per Share|COCH - Net Assets per Single Share|Vivos Therapeutics Inc. (VVOS) - Net Assets per Single Share|Accounting Value per Share enVVeno NVNO|Sintx Technologies, Inc. (SINT) - Accounting Value of a Share|Book Value per Share TNON (Tenon Medical, Inc.)|Net Asset Value per Share LFWD|AMIX: Net Assets per Single Share|Book Value of One Share INVO Bioscience IVF|Accounting Value per Share AXNX (Axonics Modulation Technologies)|Book Value per Share Biolase Inc. BIOL|Book Value per Share DYNT (Dynatronics Corp.)|FNA: Net Assets per Share|Net Assets per Single Share invobioscience.com (INVO)